🇺🇸 FDA
Patent

US 8367618

Cyclosporin analogues for preventing or treating hepatitis C infection

granted A61KA61K31/7088A61K38/13

Quick answer

US patent 8367618 (Cyclosporin analogues for preventing or treating hepatitis C infection) held by Enanta Pharmaceuticals, Inc. expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/7088, A61K38/13, A61K38/21, A61K45/00